Kolexia
Le Calloch Ronan Hématologie
Le Calloch Ronan
Hématologie
Centre hospitalier de Cornouaille
Quimper, France
129 Activités
502 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Leucémies Thrombocytémie essentielle Macroglobulinémie de Waldenström Leucémie chronique lymphocytaire à cellules B Thrombocytose Myélome multiple Maladie de Hodgkin Leucémie aigüe myéloïde

Collaborateurs

Voir plus
Le Clech Lenaig
Le Clech Lenaig
Centre hospitalier de Cornouaille, Quimper, France
Cassou Nicolas
Cassou Nicolas
Gcs Mtl Sud Finistere Site Chic, Quimper, France
Rizcallah Marie-Jeanne
Rizcallah Marie-Jeanne
Centre hospitalier de Cornouaille, Quimper, France
Laribi Kamel
Laribi Kamel
Centre Hospitalier du Mans, Le Mans, France

Industries

Voir plus
M3 Global Research Ltd
72 collaboration(s)
Dernière en 2023
Abbvie
14 collaboration(s)
Dernière en 2023
Janssen
11 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
5 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome: A Phase II Study of Venetoclax in Combination With 10-Day Decitabine in Newly Diagnosed Elderly or Relapsed/Refractory Acute Myeloid Leukemia and Relapsed High-Risk Myelodysplastic Syndrome and Blastic Plasmacytoid Dendritic Cell Neoplasm
Essai Clinique (M.D. Anderson Cancer Center)   03 janvier 2024
Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.
EJHaem   13 décembre 2023
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group.
Blood advances   23 octobre 2023
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Haematologica   01 octobre 2023
HEMVACO: Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
Essai Clinique (Centre hospitalier de Cornouaille)   29 août 2023
Comparison of efficacy and toxicity according to etoposide and cytarabine dosing in BEAM conditioning followed by autologous stem cell transplantation in Hodgkin lymphoma.
Leukemia & lymphoma   24 août 2023
Grand Prix MYÉLOME MULTIPLE 2023 – 3e lauréat – Traitement d’un plasmocytome extramédullaire par anticorps bispécifique
Edimark   19 juin 2023
Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non-Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma: A Randomized Phase II Trial Evaluating Ibrutinib Plus CD20 Ab and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   16 mars 2023
Real-World Efficacy and Safety of Venetoclax Alone and in Combination with Rituximab in Patients with Chronic Lymphocytic Leukemia: Interim Results of the Verone Study
Annual Meeting Abstracts 2022   15 novembre 2022